SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

10796	Companies
233366	Keywords
162047	Articles
124569	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 06/21/2024 at 09:30, 2 years 1 month ago

Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee
Audrey Duval Derveloy appointed Global Head of Corporate Affairs at Sanofi, joining Executive Committee. Responsible for stakeholder engagement and CSR strategy globally

Executive Committee Sanofi Audrey Duval Derveloy Corporate Affairs Global Head
BRIEF

published on 06/21/2024 at 07:05, 2 years 1 month ago

Sanofi strengthens its leadership in the treatment of hemophilia

Sanofi Fitusiran ISTH Haemophilia ALTUVIIO
PRESS RELEASE

published on 06/21/2024 at 07:00, 2 years 1 month ago

Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran
Sanofi presents new data on ALTUVIIIO and fitusiran at ISTH Congress, showcasing potential first- and best-in-class treatments for hemophilia. Fitusiran NDA under FDA review with PDUFA date of March 28, 2025

Sanofi ALTUVIIIO Fitusiran Hemophilia ISTH Congress
BRIEF

published on 06/12/2024 at 20:24, 2 years 1 month ago

Sanofi: Information on voting rights and shares - May 2024

Voting Rights Investors Actions Sanofi May 2024
PRESS RELEASE

published on 06/12/2024 at 20:19, 2 years 1 month ago

Sanofi: Information concerning the total number of voting rights and shares – May 2024
Sanofi discloses total number of voting rights and shares as per French commercial code and stock market authority regulations. Details available on Sanofi's website

Voting Rights French Commercial Code Shares Sanofi Stock Market Authority
BRIEF

published on 06/03/2024 at 22:20, 2 years 2 months ago

Phase III study: Sarclisa improves progression-free survival of patients with multiple myeloma

Multiple Myeloma Sarclisa ASCO Phase III Study Progression-free Survival
PRESS RELEASE

published on 06/03/2024 at 22:15, 2 years 2 months ago

Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3
Sarclisa in combo with VRd significantly enhances progression-free survival in newly diagnosed transplant-ineligible multiple myeloma in phase 3 study at ASCO. Full data published in NEJM

Multiple Myeloma Phase 3 Sarclisa Progression-free Survival VRd
BRIEF

published on 05/31/2024 at 12:05, 2 years 2 months ago

Sanofi Launches 2024 Global Employee Stock Purchase Plan

Financial Investment Sanofi Employee Stock Purchase Plan Action 2024 Global Participation
PRESS RELEASE

published on 05/31/2024 at 12:00, 2 years 2 months ago

Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan
Sanofi launches 2024 global Employee Stock Purchase Plan, Action 2024, offering discounted shares to 80,000 employees in 56 countries. CEO Paul Hudson affirms commitment to employee participation and company growth

Company Growth Sanofi Employee Stock Purchase Plan Action 2024 Employee Shareholders
BRIEF

published on 05/31/2024 at 07:10, 2 years 2 months ago

CHMP recommends approval of Dupixent in the EU for the treatment of patients with COPD

Sanofi COPD Dupixent CHMP Supply

Accesswire

Published on 08/03/2026 at 23:00, 6 hours 42 minutes ago

Viemed Healthcare Announces Second Quarter 2026 Financial Results
Published on 08/01/2026 at 01:20, 3 days 4 hours ago

Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 3 days 4 hours ago

Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 3 days 5 hours ago

Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/01/2026 at 00:25, 3 days 5 hours ago

BioNxt Solutions Announces Option Grants

View all ACCESSWIRE

EQS Group

Published on 08/04/2026 at 04:30, 1 hour 12 minutes ago

ADTRAN Holdings, Inc. reports second quarter 2026 financial results
Published on 08/04/2026 at 04:30, 1 hour 12 minutes ago

Adtran Networks SE announces results for Q2 2026
Published on 08/03/2026 at 23:33, 6 hours 9 minutes ago

EQS-Adhoc: Verbio SE: Preliminary EBITDA for FY 2025/2026 exceeds forecast
Published on 08/03/2026 at 23:20, 6 hours 22 minutes ago

DeFi Technologies Announces Shareholder Call to Discuss Q2 2026 Financial Results
Published on 08/03/2026 at 21:39, 8 hours 3 minutes ago

PAUL Tech AG reports net income after tax of EUR 3.2 million for fiscal year 2025 and issues a positive outlook for fiscal year 2026

Les Echos

Published on 08/03/2026 at 18:45, 10 hours 57 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 08/03/2026 at 18:00, 11 hours 42 minutes ago

H1 2026 revenue
Published on 08/03/2026 at 17:45, 11 hours 57 minutes ago

Monthly disclosure of the total number of shares and voting rights - July 2026
Published on 08/03/2026 at 17:45, 11 hours 57 minutes ago

Weekly share buyback
Published on 08/03/2026 at 17:40, 12 hours 2 minutes ago

Eiffage announces the end of exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany

View all LES ECHOS COMFI WIRE